19 May 2013
Keywords: aventis, regeneron, start, clinical, program, vegf, trap
Article | 15 March 2004
Regeneron Pharmaceuticals of the USA and Franco-German drug major Aventis have initiated clinical studies for Vascular Endothelial Growth
Factor Trap, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
15 March 2004
17 May 2013
© 2013 thepharmaletter.com